Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-10 4:57 pm Purchase | 2023-12-31 | 13G | Replimune Group, Inc. REPL | Baker Bros. Advisors LP | 9,545,336 16.200% | 3,777,109 (+65.48%) | Filing History |
| 2023-02-14 4:22 pm Purchase | 2022-12-31 | 13G | Replimune Group, Inc. REPL | Redmile Group LLC | 5,740,099 9.900% | 574,968 (+11.13%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Replimune Group, Inc. REPL | Baker Bros. Advisors LP | 5,768,227 9.990% | 5,768,227 (New Position) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Replimune Group, Inc. REPL | T. Rowe Price Associates, Inc. | 5,064,744 9.200% | -803,894 (-13.70%) | Filing History |
| 2023-02-13 4:49 pm Sale | 2022-12-31 | 13G | Replimune Group, Inc. REPL | Omega Fund IV L.P. | 3,610,478 7.200% | -1,445,074 (-28.58%) | Filing History |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | Replimune Group, Inc. REPL | BlackRock Inc. BLK | 3,010,552 5.500% | 3,010,552 (New Position) | Filing History |
| 2022-12-06 5:00 pm Sale | 2022-11-23 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X L.P. | 1,498,635 3.000% | -665,402 (-30.75%) | Filing History |
| 2022-11-18 5:17 pm Purchase | 2022-11-14 | 13G | Replimune Group, Inc. REPL | Redmile Group LLC | 5,165,131 9.900% | 389,670 (+8.16%) | Filing History |
| 2022-09-14 5:06 pm Sale | 2022-09-12 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X L.P. | 2,164,037 4.400% | -360,829 (-14.29%) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Replimune Group, Inc. REPL | Redmile Group LLC | 4,775,461 9.900% | 117,418 (+2.52%) | Filing History |
| 2022-02-14 3:18 pm Sale | 2021-12-31 | 13G | Replimune Group, Inc. REPL | Omega Fund IV L.P. | 5,055,552 10.600% | -274,231 (-5.15%) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Replimune Group, Inc. REPL | T. Rowe Price Associates, Inc. | 5,868,638 12.500% | 799,188 (+15.76%) | Filing History |
| 2022-02-09 10:24 am Sale | 2022-02-08 | 13G | Replimune Group, Inc. REPL | FMR LLC | 1,054,119 2.247% | -1,572,298 (-59.86%) | Filing History |
| 2021-07-12 2:57 pm Purchase | 2021-06-30 | 13G | Replimune Group, Inc. REPL | T. Rowe Price Associates, Inc. | 5,069,450 10.800% | 2,443,759 (+93.07%) | Filing History |
| 2021-02-16 4:11 pm Purchase | 2020-12-31 | 13G | Replimune Group, Inc. REPL | Redmile Group LLC | 4,658,043 9.900% | 1,036,408 (+28.62%) | Filing History |
| 2021-02-16 4:05 pm Sale | 2020-12-31 | 13G | Replimune Group, Inc. REPL | Coffin Robert | 2,307,300 4.900% | -234,127 (-9.21%) | Filing History |
| 2021-02-16 3:15 pm Sale | 2020-12-31 | 13G | Replimune Group, Inc. REPL | BCLS I Investco, LP | 0 0.000% | -2,575,360 (Position Closed) | Filing History |
| 2021-02-16 12:23 pm Purchase | 2020-12-31 | 13G | Replimune Group, Inc. REPL | T. Rowe Price Associates, Inc. | 2,625,691 5.700% | 2,625,691 (New Position) | Filing History |
| 2021-02-16 06:36 am Unchanged | 2020-12-31 | 13G | Replimune Group, Inc. REPL | Forbion Capital Fund III Cooperatief U.A. | 5,115,121 11.130% | 0 (Unchanged) | Filing History |
| 2021-02-11 5:12 pm Sale | 2020-12-31 | 13G | Replimune Group, Inc. REPL | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,309,109 (Position Closed) | Filing History |